Accellacare US Inc

1. Pfizer Inc. $33,197,302 1,855 payments
2. Bavarian Nordic A/S $15,261,574 850 payments
3. Regeneron Pharmaceuticals, Inc. $11,816,933 1,452 payments
4. Genentech, Inc. $6,189,598 507 payments
5. Moderna TX, Inc. $5,267,171 616 payments
6. GlaxoSmithKline, LLC. $5,199,537 810 payments
7. AbbVie, Inc. $2,824,142 389 payments
8. Hoffmann-La Roche Limited $2,806,819 137 payments
9. Novavax Inc $2,224,188 111 payments
10. BioNTech SE $1,580,706 325 payments

1. A Phase 3 Randomized Observerblinded Study to Evaluate the Efficacy Safety Tolerability and Immunogenicity of A Modified Rna Vaccine Against Influenza Compared to Licensed Inactivated Influenza Vaccine in Healthy Adults 18 Years of Age Or Older $15,390,055 553 payments
2. A Randomized, Double-Blind Study of The Efficacy and Safety of Trevogrumab, With or Without Garetosmab, in Addition to Semaglutide in Patients With Obesity $9,562,163 1,406 payments
3. A Randomized, Double-blind, Phase 3 Trial to Assess Clinical Efficacy, Safety and Reactogenicity of the Recombinant MVA-BN -RSVVaccine in Adults 60 Years of Age $8,334,020 608 payments
4. Nct05238025 $6,927,554 242 payments
5. A Phase 3 Master Protocol to Evaluate Additional Doses of Bnt162b2 in Healthy Individuals Previously Vaccinated With Bnt162b2 $4,886,178 296 payments
6. A Phase 3 Study to Evaluate the Efficacy Immunogenicity and Safety of Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Adults $4,600,595 210 payments
7. CT-388-104 OW/OB with T2D $3,888,434 490 payments
8. Effect of RO7204239 in combination with tirzepatide in participants with overweight or obesity $2,980,635 163 payments
9. Phase 2 study to evaluate RO7795081 on participants with obesity or overweight with one comorbidity $2,737,614 130 payments
10. A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients With COVID-19 $2,032,280 20 payments

1. Other $311,338 36 payments
2. Patient care $164,182 75 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.